CytoMed Therapeutics Limited (GDTC)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 22.85M |
| Enterprise value | 16.54M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 2.74 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -31.01% |
| S&P500 52-week change 3 | 26.24% |
| 52-week high 3 | 9.2500 |
| 52-week low 3 | 1.8900 |
| 50-day moving average 3 | 2.0799 |
| 200-day moving average 3 | 3.0043 |
Share statistics
| Avg vol (3-month) 3 | 4.62k |
| Avg vol (10-day) 3 | 4.5k |
| Shares outstanding 5 | 11.54M |
| Implied shares outstanding 6 | 11.6M |
| Float 8 | 3.55M |
| % held by insiders 1 | 69.27% |
| % held by institutions 1 | 0.04% |
| Shares short (15 May 2024) 4 | 38.47k |
| Short ratio (15 May 2024) 4 | 5.68 |
| Short % of float (15 May 2024) 4 | 2.26% |
| Short % of shares outstanding (15 May 2024) 4 | 0.33% |
| Shares short (prior month 15 Apr 2024) 4 | 39.35k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in SGD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -811.27% |
Management effectiveness
| Return on assets (ttm) | -27.30% |
| Return on equity (ttm) | -69.87% |
Income statement
| Revenue (ttm) | 507.74k |
| Revenue per share (ttm) | 0.05 |
| Quarterly revenue growth (yoy) | -22.80% |
| Gross profit (ttm) | N/A |
| EBITDA | -3.46M |
| Net income avi to common (ttm) | -4.13M |
| Diluted EPS (ttm) | -0.2900 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 9M |
| Total cash per share (mrq) | 0.78 |
| Total debt (mrq) | 448.02k |
| Total debt/equity (mrq) | 3.98% |
| Current ratio (mrq) | 14.08 |
| Book value per share (mrq) | 0.98 |
Cash flow statement
| Operating cash flow (ttm) | -3.43M |
| Levered free cash flow (ttm) | -2.04M |
© 2024 Yahoo. All rights reserved.